MoonLake Immunotherapeutics MLTX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from MoonLake Immunotherapeutics’s reported figures.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's free cash flow?
- MoonLake Immunotherapeutics (MLTX) reported free cash flow of -$66.29M in Q1 2026.
- How has MoonLake Immunotherapeutics's free cash flow changed year-over-year?
- MoonLake Immunotherapeutics's free cash flow decreased by 73.6% year-over-year, from -$38.18M to -$66.29M.
- What is the long-term trend for MoonLake Immunotherapeutics's free cash flow?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's free cash flow has grown at a 51.9% compound annual growth rate (CAGR), from -$55.91M to -$196.04M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.